AvePoint, Inc. provides cloud-native data management software platform in North America, Europe, the Middle East, Africa, and the Asia Pacific. It also provides platform-as-a-service architecture to address critical operational challenges and the management of data to organizations that leverage third-party cloud vendors, including Microsoft, Salesforce, Google, AWS, Box, DropBox, and others; license and support; and maintenance services. Further, it provides AvePoint confidence platform including control suite, automates data governance, enforces policies, and optimizes SaaS investments, enables expense management and reduction, and provides insight into access, risk, and entitlements across collaborative platforms; resilience suite, that supports business continuity and compliance through Backup-as-a-Service, ransomware recovery, lifecycle management, and classification-driven protection; and modernization suite, that modernizes legacy systems and processes into AI-ready, SaaS-based experiences to accelerate employee engagement, digital transformation, and productivity. AvePoint, Inc. was incorporated in 2001 and is headquartered in Jersey City, New Jersey.…
Is AvePoint (AVPT) Outperforming Other Computer and Technology Stocks This Year?
AvePoint (NASDAQ: AVPT) is listed on Nasdaq, where its shares trade in USD. It belongs to the Software - Infrastructure industry, part of the Technology sector, and reports about 3,443 employees.
The shares were at 16.49 USD on 20 November 2026, up 36.5% over 52 weeks. Its 52-week range is 8.835 USD to 17.52 USD: the price is 5.9% below the high and 86.6% above the low.
At a market capitalisation of 3.46B USD, it trades at 48.5 times trailing earnings and 32.2 times forward earnings. The median trailing P/E of its 14 largest Software - Infrastructure peers is 36.9, a premium of 32% for AVPT.
AvePoint reports return on equity of 7.3%, an operating margin of 9.5% and revenue up 19.5% year over year.
It holds more cash than debt, a net cash position of 388.40M USD. Its Piotroski F-score is 6 out of 9, an average reading of its financial health. 14 analysts cover the stock, with an average rating of Buy; their mean price target of 19.61 USD is 18.9% above the current price. The next earnings report is expected on 25 February 2027.